BioXcel Therapeutics Inc (BTAI)
2.57
+0.01
(+0.39%)
USD |
NASDAQ |
May 03, 16:00
2.57
0.00 (0.00%)
After-Hours: 20:00
BioXcel Therapeutics Gross Profit (Quarterly): -0.338M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.338M |
| September 30, 2023 | -0.171M |
| June 30, 2023 | 0.431M |
| March 31, 2023 | 0.197M |
| December 31, 2022 | 0.229M |
| Date | Value |
|---|---|
| September 30, 2022 | 0.126M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-0.338M
Minimum
Dec 2023
0.431M
Maximum
Jun 2023
0.0474M
Average
--
Median
Sep 2021
Gross Profit (Quarterly) Benchmarks
| Synlogic Inc | -- |
| Cormedix Inc | 0.00 |
| Bristol-Myers Squibb Co | 8.933B |
| Verastem Inc | -- |
| Ocular Therapeutix Inc | 13.42M |